{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T10:34:30Z","timestamp":1793183670484,"version":"4.5.0"},"reference-count":154,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Atopic dermatitis (AD) and alopecia areata (AA) have traditionally been regarded as inflammatory dermatoses with independent pathogenic mechanisms, with the former mostly categorized as a type 2 inflammatory disease and the latter as a type 1 inflammatory disease. However, immunologic studies have shown that the immunologic properties of AD and AA do not strictly follow the traditional classification. Both diseases are associated with systemic Th1, Th2, Th17, and Th22 cytokine imbalances, shared genetic susceptibility loci, overlapping immune pathways, and microbiome-mediated modulation of skin pathology. This review systematically investigates the intricate interactions between AD and AA, focusing on shared pathophysiologic mechanisms such as immune network crosstalk, metabolic dysregulation, and microbial influences. Furthermore, it critically evaluates current therapeutic strategies for overlapping disease manifestations, with a detailed analysis of emerging targeted therapies and their implications for clinical practice. By integrating existing evidence and identifying research gaps, this article aims to provide new perspectives on the understanding of the mechanisms of AD-AA interactions and to inform clinical decision-making and future research directions.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1641918","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T05:37:22Z","timestamp":1756877842000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Overlapping features of atopic dermatitis and alopecia areata: from pathogenesis to treatment"],"prefix":"10.3389","volume":"16","author":[{"given":"Jiayi","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yugu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19580","article-title":"The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990-2017","volume":"184","author":"Laughter","year":"2021","journal-title":"Br J Dermatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.08.032","article-title":"Epidemiology of alopecia areata, ophiasis, totalis, and universalis: A systematic review and meta-analysis","volume":"82","author":"Lee","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2017.04.1141","article-title":"Alopecia areata: Disease characteristics, clinical evaluation, and new perspectives on pathogenesis","volume":"78","author":"Strazzulla","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2023911","article-title":"Atopic dermatitis","volume":"384","author":"St\u00e4nder","year":"2021","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25115652","article-title":"Deciphering the complex immunopathogenesis of alopecia areata","volume":"25","author":"\u0160uti\u0107 Udovi\u0107","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B6","first-page":"59","article-title":"The gut and skin microbiome in alopecia: associations and interventions","volume":"16","author":"Carrington","year":"2023","journal-title":"J Clin Aesthet Dermatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/all.13128","article-title":"Incident alopecia areata and vitiligo in adult women with atopic dermatitis: Nurses\u2019 Health Study 2","volume":"72","author":"Drucker","year":"2017","journal-title":"Allergy"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/cea.13729","article-title":"Bidirectional association between alopecia areata and atopic dermatitis: A population-based cohort study in Taiwan","volume":"50","author":"Wei","year":"2020","journal-title":"Clin Exp Allergy"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.jaip.2020.01.052","article-title":"Alopecia areata is associated with atopic diathesis: results from a population-based study of 51,561 patients","volume":"8","author":"Kridin","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2014.26.6.722","article-title":"Differences in comorbidity profiles between early-onset and late-onset alopecia areata patients: A retrospective study of 871 Korean patients","volume":"26","author":"Lee","year":"2014","journal-title":"Ann Dermatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16727","article-title":"Comorbidities in pediatric alopecia areata","volume":"34","author":"Conic","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00149-X","article-title":"Atopic dermatitis","volume":"387","author":"Weidinger","year":"2016","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jdermsci.2010.02.008","article-title":"Extrinsic and intrinsic types of atopic dermatitis","volume":"58","author":"Tokura","year":"2010","journal-title":"J Dermatol Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052618","article-title":"Immunological properties of atopic dermatitis-associated alopecia areata","volume":"22","author":"Kageyama","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1172\/JCI21060","article-title":"New insights into atopic dermatitis","volume":"113","author":"Leung","year":"2004","journal-title":"J Clin Invest"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.07.012","article-title":"Progressive activation of T(H)2\/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis","volume":"130","author":"Gittler","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-3-319-64804-0_3","article-title":"Atopic dermatitis: pathophysiology","volume":"1027","author":"David Boothe","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3645","article-title":"Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition","volume":"20","author":"Xing","year":"2014","journal-title":"Nat Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.5546\/aap.2017.eng.e404","article-title":"Alopecia Areata. Current situation and perspectives","volume":"115","author":"Ju\u00e1rez-Rend\u00f3n","year":"2017","journal-title":"Arch Argent Pediatr"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21155382","article-title":"Regulation of filaggrin, loricrin, and involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: pathogenic implications in atopic dermatitis","volume":"21","author":"Furue","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/cells10123397","article-title":"The role of serum th1, th2, and th17 cytokines in patients with alopecia areata: clinical implications","volume":"10","author":"Wa\u015bkiel-Burnat","year":"2021","journal-title":"Cells"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2016.1135898","article-title":"Recent considerations in the use of recombinant interferon gamma for biological therapy of atopic dermatitis","volume":"16","author":"Brar","year":"2016","journal-title":"Expert Opin Biol Ther"},{"key":"B23","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1515\/bmc-2018-0007","article-title":"Interferon-gamma (IFN-\u03b3): Exploring its implications in infectious diseases","volume":"9","author":"Kak","year":"2018","journal-title":"Biomol Concepts"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2017.29.2.156","article-title":"The contributory roles of th17 lymphocyte and cytotoxic T lymphocyte at the hair bulge region as well as the hair bulb area in the chronic alopecia areata patients","volume":"29","author":"Hong","year":"2017","journal-title":"Ann Dermatol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2017.4312","article-title":"Th1\/Th2 PB balance and CD200 expression of patients with active severe alopecia areata","volume":"13","author":"Ma","year":"2017","journal-title":"Exp Ther Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.15658","article-title":"IFN-\u03b1 and TNF-\u03b1 serum levels and their association with disease severity in Egyptian children and adults with alopecia areata","volume":"60","author":"Omar","year":"2021","journal-title":"Int J Dermatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16808","article-title":"Alopecia areata: a review of disease pathogenesis","volume":"179","author":"Rajabi","year":"2018","journal-title":"Br J Dermatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25116158","article-title":"Characterization of high and low IFNG-expressing subgroups in atopic dermatitis","volume":"25","author":"Wasserer","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052684","article-title":"Multiple\u00a0roles for cytokines in atopic dermatitis: from pathogenic mediators to endotype-specific biomarkers to therapeutic targets","volume":"23","author":"Fania","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00353","article-title":"Regulation of T cell immunity in atopic dermatitis by microbes: the yin and yang of cutaneous inflammation","volume":"6","author":"Biedermann","year":"2015","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14425","article-title":"Interferon-\u03b3 downregulates tight junction function, which is rescued by interleukin-17A","volume":"30","author":"Mizutani","year":"2021","journal-title":"Exp Dermatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.364","article-title":"Interferon-\u03b3 decreases ceramides with long-chain fatty acids: possible involvement in atopic dermatitis and psoriasis","volume":"134","author":"Tawada","year":"2014","journal-title":"J Invest Dermatol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14129","article-title":"Understanding the significance of cytokines and chemokines in the pathogenesis of alopecia areata","volume":"29","author":"Ito","year":"2020","journal-title":"Exp Dermatol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/cei.13575","article-title":"Keratinocytes: innate immune cells in atopic dermatitis","volume":"204","author":"Chieosilapatham","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/ng1767","article-title":"Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis","volume":"38","author":"Palmer","year":"2006","journal-title":"Nat Genet"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2007.02.010","article-title":"Interleukin-4 depresses levels of transcripts for acid-sphingomyelinase and glucocerebrosidase and the amount of ceramide in acetone-wounded epidermis, as demonstrated in a living skin equivalent","volume":"47","author":"Hatano","year":"2007","journal-title":"J Dermatol Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12047","article-title":"The Th2 cytokine, interleukin-4, abrogates the cohesion of normal stratum corneum in mice: implications for pathogenesis of atopic dermatitis","volume":"22","author":"Hatano","year":"2013","journal-title":"Exp Dermatol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.12273","article-title":"Serum thymus and activation-regulated chemokine as disease activity and response biomarker in alopecia areata","volume":"40","author":"Inui","year":"2013","journal-title":"J Dermatol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12396","article-title":"T-helper and regulatory T-cell cytokines in the peripheral blood of patients with active alopecia areata","volume":"169","author":"Tembhre","year":"2013","journal-title":"Br J Dermatol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.696784","article-title":"Th2 modulation of transient receptor potential channels: an unmet therapeutic intervention for atopic dermatitis","volume":"12","author":"Meng","year":"2021","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.08.032","article-title":"Comorbidity profiles among patients with alopecia areata: the importance of onset age, a nationwide population-based study","volume":"65","author":"Chu","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/all.13346","article-title":"Alopecia areata is characterized by expansion of circulating Th2\/Tc2\/Th22, within the skin-homing and systemic T-cell populations","volume":"73","author":"Czarnowicki","year":"2018","journal-title":"Allergy"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22084130","article-title":"Molecular mechanisms of atopic dermatitis pathogenesis","volume":"22","author":"Sroka-Tomaszewska","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.7.4733","article-title":"Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis","volume":"181","author":"Kryczek","year":"2008","journal-title":"J Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2012.8","article-title":"Endogenous, or therapeutically induced, type I interferon responses differentially modulate Th1\/Th17-mediated autoimmunity in the CNS","volume":"90","author":"Kalinke","year":"2012","journal-title":"Immunol Cell Biol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1600126","article-title":"Expression of IL-22 in the skin causes th2-biased immunity, epidermal barrier dysfunction, and pruritus via stimulating epithelial th2 cytokines and the GRP pathway","volume":"198","author":"Lou","year":"2017","journal-title":"J Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/s41467-020-15230-y","article-title":"Exploration of sensory and spinal neurons expressing gastrin-releasing peptide in itch and pain related behaviors","volume":"11","author":"Barry","year":"2020","journal-title":"Nat Commun"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e2216230120","DOI":"10.1073\/pnas.2216230120","article-title":"Structures of human gastrin-releasing peptide receptors bound to antagonist and agonist for cancer and itch therapy","volume":"120","author":"Peng","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B49","doi-asserted-by":"publisher","first-page":"84","DOI":"10.2500\/aap.2019.40.4202","article-title":"Pathophysiology of atopic dermatitis: Clinical implications","volume":"40","author":"Kim","year":"2019","journal-title":"Allergy Asthma Proc"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1159\/000350933","article-title":"Alopecia areata: infiltration of Th17 cells in the dermis, particularly around hair follicles","volume":"226","author":"Tanemura","year":"2013","journal-title":"Dermatology"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.12808","article-title":"T-helper 17 cytokines (interleukins 17, 21, 22, and 6, and tumor necrosis factor-\u03b1) in patients with alopecia areata: association with clinical type and severity","volume":"55","author":"Atwa","year":"2016","journal-title":"Int J Dermatol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.12994","article-title":"Serum level of interleukin-17A in patients with alopecia areata and its relationship to age","volume":"55","author":"El-Morsy","year":"2016","journal-title":"Int J Dermatol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201242613","article-title":"Chronic exposure to stress predisposes to higher autoimmune susceptibility in C57BL\/6 mice: glucocorticoids as a double-edged sword","volume":"43","author":"Harpaz","year":"2013","journal-title":"Eur J Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jaad.2015.09.045","article-title":"A systematic review of pulse steroid therapy for alopecia areata","volume":"74","author":"Shreberk-Hassidim","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18008","article-title":"Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease-associated psychological morbidity","volume":"182","author":"Bain","year":"2020","journal-title":"Br J Dermatol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.4161\/jkst.24137","article-title":"The involvement of the JAK-STAT signaling pathway in chronic inflammatory skin disease atopic dermatitis","volume":"2","author":"Bao","year":"2013","journal-title":"Jakstat"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.2.984","article-title":"IL-4 and IL-13 negatively regulate TNF-alpha- and IFN-gamma-induced beta-defensin expression through STAT-6, suppressor of cytokine signaling (SOCS)-1, and SOCS-3","volume":"179","author":"Albanesi","year":"2007","journal-title":"J Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901860","article-title":"IL-4 regulates skin homeostasis and the predisposition toward allergic skin inflammation","volume":"184","author":"Sehra","year":"2010","journal-title":"J Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"153477","DOI":"10.1016\/j.prp.2021.153477","article-title":"STAT6: A review of a signaling pathway implicated in various diseases with a special emphasis in its usefulness in pathology","volume":"223","author":"Karpathiou","year":"2021","journal-title":"Pathol Res Pract"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.2001.01191.x","article-title":"Novel dinucleotide repeat polymorphism in the first exon of the STAT-6 gene is associated with allergic diseases","volume":"31","author":"Tamura","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3912","article-title":"STAT3-dependent reactive astrogliosis in the spinal dorsal horn underlies chronic itch","volume":"21","author":"Shiratori-Hayashi","year":"2015","journal-title":"Nat Med"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/nature09114","article-title":"Genome-wide association study in alopecia areata implicates both innate and adaptive immunity","volume":"466","author":"Petukhova","year":"2010","journal-title":"Nature"},{"key":"B63","doi-asserted-by":"publisher","first-page":"5966","DOI":"10.1038\/ncomms6966","article-title":"Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci","volume":"6","author":"Betz","year":"2015","journal-title":"Nat Commun"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1500973","article-title":"Pharmacologic inhibition of JAK-STAT signaling promotes hair growth","volume":"1","author":"Harel","year":"2015","journal-title":"Sci Adv"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.11.037","article-title":"Response to tofacitinib therapy of eyebrows and eyelashes in alopecia areata","volume":"80","author":"Liu","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.10.036","article-title":"Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers","volume":"149","author":"Guttman-Yassky","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.89790","article-title":"Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata","volume":"1","author":"Mackay-Wiggan","year":"2016","journal-title":"JCI Insight"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2009.00766.x","article-title":"The significance of OX40 and OX40L to T-cell biology and immune disease","volume":"229","author":"Croft","year":"2009","journal-title":"Immunol Rev"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2012.04587.x","article-title":"OX40 ligand and OX40 are increased in atopic dermatitis lesions but do not correlate with clinical severity","volume":"27","author":"Ilves","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1084\/jem.193.3.387","article-title":"Development of allergic inflammation in a murine model of asthma is dependent on the costimulatory receptor OX40","volume":"193","author":"Jember","year":"2001","journal-title":"J Exp Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1172\/JCI33559","article-title":"In vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammation","volume":"117","author":"Seshasayee","year":"2007","journal-title":"J Clin Invest"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljae230","article-title":"The role of OX40 ligand\/OX40 axis signalling in atopic dermatitis","volume":"191","author":"Guttman-Yassky","year":"2024","journal-title":"Br J Dermatol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-023-00838-9","article-title":"OX40 in the pathogenesis of atopic dermatitis-A new therapeutic target","volume":"25","author":"Croft","year":"2024","journal-title":"Am J Clin Dermatol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jaci.2018.11.053","article-title":"GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis","volume":"144","author":"Guttman-Yassky","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.05.013","article-title":"The costimulatory receptor OX40 inhibits interleukin-17 expression through activation of repressive chromatin remodeling pathways","volume":"44","author":"Xiao","year":"2016","journal-title":"Immunity"},{"key":"B76","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jid.2023.06.201","article-title":"Mast cells initiate type 2 inflammation through tryptase released by MRGPRX2\/MRGPRB2 activation in atopic dermatitis","volume":"144","author":"Jia","year":"2024","journal-title":"J Invest Dermatol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.08.018","article-title":"CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction","volume":"29","author":"Gri","year":"2008","journal-title":"Immunity"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094260","article-title":"Abnormal interactions between perifollicular mast cells and CD8+ T-cells may contribute to the pathogenesis of alopecia areata","volume":"9","author":"Bertolini","year":"2014","journal-title":"PloS One"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-015-1539-1","article-title":"Lesional infiltration of mast cells, Langerhans cells, T cells and local cytokine profiles in alopecia areata","volume":"307","author":"Zhang","year":"2015","journal-title":"Arch Dermatol Res"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14155","article-title":"Hair follicle immune privilege and its collapse in alopecia areata","volume":"29","author":"Bertolini","year":"2020","journal-title":"Exp Dermatol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-05-220004","article-title":"Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40\/OX40L axis toward Th17-cell differentiation","volume":"114","author":"Piconese","year":"2009","journal-title":"Blood"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00394","article-title":"Mast cells as regulators of T cell responses","volume":"6","author":"Bulfone-Paus","year":"2015","journal-title":"Front Immunol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1111\/all.16268","article-title":"Alopecia areata exhibits cutaneous and systemic OX40 activation across atopic backgrounds","volume":"79","author":"Kim","year":"2024","journal-title":"Allergy"},{"key":"B84","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jaip.2022.09.021","article-title":"Impact of a decade of research into atopic dermatitis","volume":"11","author":"Arkwright","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B85","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jdermsci.2015.01.004","article-title":"The genetics of alopecia areata: new approaches, new findings, new treatments","volume":"78","author":"Biran","year":"2015","journal-title":"J Dermatol Sci"},{"key":"B86","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.abd.2024.06.001","article-title":"Update on the pathogenesis of atopic dermatitis","volume":"99","author":"Criado","year":"2024","journal-title":"Anais Brasileiros Dermatologia"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3424","article-title":"Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis","volume":"47","author":"Paternoster","year":"2015","journal-title":"Nat Genet"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186484","article-title":"Genetic and epigenetic aspects of atopic dermatitis","volume":"21","author":"Nedoszytko","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-015-8508-5","article-title":"The genetics and epigenetics of atopic dermatitis-filaggrin and other polymorphisms","volume":"51","author":"Liang","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.05.004","article-title":"Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations","volume":"118","author":"Weidinger","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700915","article-title":"Loss-of-function mutations in the filaggrin gene and alopecia areata: strong risk factor for a severe course of disease in patients comorbid for atopic disease","volume":"127","author":"Betz","year":"2007","journal-title":"J Invest Dermatol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000265","article-title":"Interleukin 4 -590C\/T (rs2243250) polymorphism is associated with increased risk of atopic dermatitis: meta-analysis of case-control studies","volume":"28","author":"Liang","year":"2017","journal-title":"Dermatitis"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2011.01357.x","article-title":"Association of polymorphisms in genes encoding IL-4, IL-13 and their receptors with atopic dermatitis in a Korean population","volume":"20","author":"Namkung","year":"2011","journal-title":"Exp Dermatol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2013.05.086","article-title":"The association\u00a0between Interleukin (IL)-4 gene intron 3 VNTR polymorphism and alopecia areata (AA) in Turkish population","volume":"527","author":"Kalkan","year":"2013","journal-title":"Gene"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2012.129","article-title":"Follow-up study of the first genome-wide association scan in alopecia areata: IL13 and KIAA0350 as susceptibility loci supported with genome-wide significance","volume":"132","author":"Jagielska","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"96","DOI":"10.2500\/aap.2018.39.4114","article-title":"Association of alopecia areata with atopic dermatitis and chronic spontaneous urticaria","volume":"39","author":"Magen","year":"2018","journal-title":"Allergy Asthma Proc"},{"key":"B97","doi-asserted-by":"publisher","first-page":"2096995","DOI":"10.1080\/19490976.2022.2096995","article-title":"Impact of gut microbiome on skin health: gut-skin axis observed through the lenses of therapeutics and skin diseases","volume":"14","author":"Mahmud","year":"2022","journal-title":"Gut Microbes"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1281660","article-title":"Gut microbiome, metabolome and alopecia areata","volume":"14","author":"Liu","year":"2023","journal-title":"Front Microbiol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jaut.2018.12.001","article-title":"Alopecia areata: A multifactorial\u00a0autoimmune condition","volume":"98","author":"Simakou","year":"2019","journal-title":"J Autoimmun"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.15582","article-title":"Claudin-3 is a novel intestinal integrity marker in patients with alopecia areata: Correlation with the disease severity","volume":"22","author":"Rafik","year":"2023","journal-title":"J Cosmet Dermatol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.15095","article-title":"Is there a link between alopecia areata and gut","volume":"21","author":"Hac\u0131necipo\u011flu","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.4103\/ijt.ijt_76_19","article-title":"What\u2019s new in the pathophysiology of alopecia areata? The possible contribution of skin and gut microbiome in the pathogenesis of alopecia - big opportunities, big challenges, and novel perspectives","volume":"11","author":"Migacz-Gruszka","year":"2019","journal-title":"Int J Trichol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.673708","article-title":"Partners in leaky gut syndrome: intestinal dysbiosis and autoimmunity","volume":"12","author":"Kinashi","year":"2021","journal-title":"Front Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2017.11.008","article-title":"Staphylococcus aureus and atopic dermatitis: A complex and evolving relationship","volume":"26","author":"Geoghegan","year":"2018","journal-title":"Trends Microbiol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0215206","article-title":"Scalp bacterial shift in Alopecia areata","volume":"14","author":"Pinto","year":"2019","journal-title":"PloS One"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13935","article-title":"The role of the microbiome in scalp hair follicle biology and disease","volume":"29","author":"Polak-Witka","year":"2020","journal-title":"Exp Dermatol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2011.01080.x","article-title":"Microbial influences on epithelial integrity and immune function as a basis for inflammatory diseases","volume":"245","author":"Macia","year":"2012","journal-title":"Immunol Rev"},{"key":"B108","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s11033-025-10714-w","article-title":"Role of the intestinal flora-immunity axis in the pathogenesis of rheumatoid arthritis-mechanisms regulating short-chain fatty acids and Th17\/Treg homeostasis","volume":"52","author":"Lv","year":"2025","journal-title":"Mol Biol Rep"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1148359","article-title":"Novel potential therapeutic targets of alopecia areata","volume":"14","author":"Xu","year":"2023","journal-title":"Front Immunol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.4168\/aair.2020.12.1.137","article-title":"Antibiotics-induced dysbiosis of intestinal microbiota aggravates atopic dermatitis in mice by altered short-chain fatty acids","volume":"12","author":"Kim","year":"2020","journal-title":"Allergy Asthma Immunol Res"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.12978","article-title":"Imbalance of T-helper 17 and regulatory T cells in patients with alopecia areata","volume":"42","author":"Han","year":"2015","journal-title":"J Dermatol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2024.2348062","article-title":"Novel investigational drugs for alopecia areata and future perspectives","volume":"33","author":"Chim","year":"2024","journal-title":"Expert Opin Investig Drugs"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2018.11.007","article-title":"Remission of alopecia universalis in a patient with atopic dermatitis treated with dupilumab","volume":"5","author":"Smogorzewski","year":"2019","journal-title":"JAAD Case Rep"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3183","article-title":"Dupilumab improved alopecia areata in a patient with atopic dermatitis: A case report","volume":"99","author":"Uchida","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-021-08883-0","article-title":"Alopecia areata: an update on etiopathogenesis, diagnosis, and management","volume":"61","author":"Zhou","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/all.15071","article-title":"Phase 2a randomized clinical trial of dupilumab (anti-IL-4R\u03b1) for alopecia areata patients","volume":"77","author":"Guttman-Yassky","year":"2022","journal-title":"Allergy"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2019.03.019","article-title":"Alopecia areata in 2 patients treated with dupilumab: New onset and worsening","volume":"5","author":"Chung","year":"2019","journal-title":"JAAD Case Rep"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.06.010","article-title":"Cause or cure? Review of dupilumab and alopecia areata","volume":"88","author":"Marks","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.01.046","article-title":"Dupilumab therapy for alopecia areata in pediatric patients with concomitant atopic dermatitis","volume":"84","author":"McKenzie","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2021.07.015","article-title":"Dupilumab for the treatment of alopecia areata in children with atopic dermatitis","volume":"16","author":"Cho","year":"2021","journal-title":"JAAD Case Rep"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1007\/s00105-022-04982-x","article-title":"Janus kinase inhibitors for the treatment of alopecia areata","volume":"73","author":"Kobal","year":"2022","journal-title":"Hautarzt"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2023.03.011","article-title":"Biologic versus small molecule therapy for treating moderate to severe atopic dermatitis: clinical considerations","volume":"11","author":"Butala","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15346","article-title":"Upadacitinib improved alopecia areata in a patient with atopic dermatitis: A case report","volume":"35","author":"Cantelli","year":"2022","journal-title":"Dermatol Ther"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000780","article-title":"Dual efficacy of upadacitinib in 2 patients with concomitant severe atopic dermatitis and alopecia areata","volume":"32","author":"Gambardella","year":"2021","journal-title":"Dermatitis"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.05.033","article-title":"Efficacy and safety of switching from dupilumab to upadacitinib versus continuous upadacitinib in moderate-to-severe atopic dermatitis: Results from an open-label extension of the phase 3, randomized, controlled trial (Heads Up)","volume":"89","author":"Blauvelt","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-023-00889-0","article-title":"Alopecia universalis in an adolescent successfully treated with upadacitinib-A case report and review of the literature on the use of JAK inhibitors in pediatric alopecia areata","volume":"13","author":"Ko\u0142cz","year":"2023","journal-title":"Dermatol Ther (Heidelb)"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.16316","article-title":"Concurrent chronic alopecia areata and severe atopic dermatitis successfully treated with upadacitinib","volume":"61","author":"Asfour","year":"2022","journal-title":"Int J Dermatol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S458684","article-title":"Abrocitinib improved dupilumab-resistant severe atopic dermatitis with comorbid mild alopecia areata in a 12-year-old boy: A case report with 1-year follow-up","volume":"17","author":"Liu","year":"2024","journal-title":"J Asthma Allergy"},{"key":"B129","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jdcr.2022.02.027","article-title":"A case of atopic dermatitis with alopecia universalis in a patient treated with abrocitinib","volume":"22","author":"Zhao","year":"2022","journal-title":"JAAD Case Rep"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.66647","article-title":"Drug-induced alopecia areata from upadacitinib","volume":"16","author":"Chang","year":"2024","journal-title":"Cureus"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.7573\/dic.2020-8-5","article-title":"Emerging systemic JAK inhibitors in the treatment of atopic dermatitis: a review of abrocitinib, baricitinib, and upadacitinib","volume":"9","author":"Nezamololama","year":"2020","journal-title":"Drugs Context"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.3023","article-title":"Efficacy and safety of upadacitinib vs dupilumab in adults with moderate-to-severe atopic dermatitis: A randomized clinical trial","volume":"157","author":"Blauvelt","year":"2021","journal-title":"JAMA Dermatol"},{"key":"B133","unstructured":"A phase 2b study to evaluate rezpegaldesleukin (Rezpeg) in the treatment of adult patients with moderate-to-severe atopic dermatitis (REZOLVE-AD)\n          \n          \n          \n          2025"},{"key":"B134","unstructured":"A phase 2b study to evaluate rezpegaldesleukin (Rezpeg) in the treatment of severe to very severe alopecia areata in adult patients (Rezolve AA)\n          \n          \n          \n          2025"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.04.055","article-title":"Phase 2 randomized, double-blind study of IL-17 targeting with secukinumab in atopic dermatitis","volume":"147","author":"Ungar","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.jaad.2018.01.016","article-title":"Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial","volume":"78","author":"Guttman-Yassky","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-018-1853-5","article-title":"Efficacy and safety of secukinumab treatment in adults with extensive alopecia areata","volume":"310","author":"Guttman-Yassky","year":"2018","journal-title":"Arch Dermatol Res"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14122753","article-title":"OX40-OX40L inhibition for the treatment of atopic dermatitis-focus on rocatinlimab and amlitelimab","volume":"14","author":"L\u00e9","year":"2022","journal-title":"Pharmaceutics"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.2332\/allergolint.13-OA-0683","article-title":"Effects of bifidobacterial supplementation to pregnant women and infants in the prevention of allergy development in infants and on fecal microbiota","volume":"63","author":"Enomoto","year":"2014","journal-title":"Allergol Int"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2011.12.012","article-title":"Effect of environmental tobacco smoke on atopic dermatitis among children in Korea","volume":"113","author":"Yi","year":"2012","journal-title":"Environ Res"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0904055107","article-title":"Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders","volume":"107","author":"Kwon","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e31826a8468","article-title":"Probiotics reduce gut microbial translocation and improve adult atopic dermatitis","author":"Iemoli","year":"2012","journal-title":"J Clin Gastroenterol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2013-305799","article-title":"Probiotics in the prevention of eczema: a randomised controlled trial","volume":"99","author":"Allen","year":"2014","journal-title":"Arch Dis Child"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20102534","article-title":"Health benefits of heat-killed (Tyndallized) probiotics: an overview","volume":"20","author":"Piqu\u00e9","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00507","article-title":"Probiotics and atopic dermatitis: an overview","volume":"7","author":"Rather","year":"2016","journal-title":"Front Microbiol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1111\/all.16372","article-title":"Fecal microbiota transplantation against moderate-to-severe atopic dermatitis: A randomized, double-blind controlled explorer trial","volume":"80","author":"Liu","year":"2025","journal-title":"Allergy"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.14309\/crj.2017.107","article-title":"Hair growth in two alopecia patients after fecal microbiota transplant","volume":"4","author":"Rebello","year":"2017","journal-title":"ACG Case Rep J"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-017-0285-x","article-title":"The role of micronutrients in alopecia areata: A review","volume":"18","author":"Thompson","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.07.051","article-title":"Vitamin D deficiency in patients with alopecia areata: A systematic review and meta-analysis","volume":"78","author":"Tsai","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2009.04637.x","article-title":"Reversing bacteria-induced vitamin D receptor dysfunction is key to autoimmune disease","volume":"1173","author":"Waterhouse","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v7.i19.3074","article-title":"Hair regrowth following fecal microbiota transplantation in an elderly patient with alopecia areata: A case report and review of the literature","volume":"7","author":"Xie","year":"2019","journal-title":"World J Clin Cases"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2024.2326625","article-title":"Microbiome modulators for atopic eczema: a systematic review of experimental and investigational therapeutics","volume":"33","author":"Greenzaid","year":"2024","journal-title":"Expert Opin Investig Drugs"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1243556","article-title":"Inhibition of T-cell activity in alopecia areata: recent developments and new directions","volume":"14","author":"Passeron","year":"2023","journal-title":"Front Immunol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9020353","article-title":"Gut-skin axis: current knowledge of the interrelationship between microbial dysbiosis and skin conditions","volume":"9","author":"De Pessemier","year":"2021","journal-title":"Microorganisms"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1641918\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T05:37:25Z","timestamp":1756877845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1641918\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":154,"alternative-id":["10.3389\/fimmu.2025.1641918"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1641918","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,3]]},"article-number":"1641918"}}